FDA approves first new type of pain medication in 25 years
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
Chocolate Recall Updated to Highest Risk Level, FDA Warns Consumption Could Cause Death
The FDA has updated the December recall of some of Cal Yee Farms' products to the highest risk level classification for three ...
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
STAT9d
FDA purges material on clinical trial diversity from its site, showing stakes of Trump DEI ban
Following the Trump administration's DEI ban, the FDA's move to scrub webpages has ensnared many pages focused on ensuring ...
People3d
FDA Approves Ozempic to Treat Kidney Disease
Ozempic becomes the first GLP-1 treatment option for people with type 2 diabetes and chronic kidney disease Mario Tama/Getty The Food and Drug Administration has approved Ozempic to reduce the ...
BioSpace4d
How Might the FDA Evolve Under RFK Jr. and Makary?
Ahead of Robert F. Kennedy Jr.’s confirmation hearings, experts—and RFK’s own family—expressed concerns about his vaccine-related views, though the same experts are largely unfazed by the level of ...
Chocolate recall elevated by FDA on products sold in Tennessee. Here's what to know
Nine states have been identified as being affected by the chocolate recall, but the products were available online so others could have the products as well. Consumers affected bought products from ...
Chocolate Recall Update As FDA Sets Highest Risk Level for 9 States
A recall which was issued across nine states has now been given the highest risk classification by the federal agency.
FDA upgrades Oregon, Washington recall for Lay's Classic Potato Chips to highest level
The FDA upgraded a recall for Lay's Classic Potato Chips to the highest risk level for packages distributed in Oregon and Washington.
FDA approves new type of nonopioid painkiller for acute pain
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
The FDA pulls key DEI initiative for cancer studies from its website
A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...